Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Transient Ischemic Attack l: Introduction

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...

Ischemic Stroke l: Introduction

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.

Ischemic Stroke ll: Pathophysiology

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...

Ischemic Heart Disease: Overview

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...

Acute Coronary Syndrome IV: Interprofessional Care

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

HIV, nephrotoxic medications, and chronic kidney disease: Prevalence, risk factors, and mediation analyses among people with and without HIV enrolled in the Multicenter AIDS Cohort Study (MACS)/ Women's Interagency HIV Study (WIHS) combined cohort study.

PloS one·2026

Same author

Results from an international multi-center prospective registry of cardiac catheterizations and percutaneous cardiac interventions guided with three-dimensional imaging.

Postepy w kardiologii interwencyjnej = Advances in interventional cardiology·2026

Same author

Antithrombotic Therapy for Noncardioembolic Ischemic Stroke: Current Evidence and Future Directions.

Stroke·2026

Same author

Role of CT Perfusion Imaging in Patients With Minor Stroke: A Cohort Study.

The Neurohospitalist·2026

Same author

Liberal Versus Restrictive Transfusion Strategy in Patients With Subarachnoid Hemorrhage: A Meta-Analysis.

Stroke (Hoboken, N.J.)·2026

Same author

The Diabetes Education Arena: Results of the 2025 ADCES National Practice Survey of Diabetes Care and Education Specialists.

The science of diabetes self-management and care·2026

Search research articles

Related Experiment Video

Updated: Jul 3, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Transient ischemic attack: risk stratification and treatment.

Brett Cucchiara¹, Michael Ross

¹Department of Neurology, University of Pennsylvania Medical Center, Philadelphia, PA 19104, USA. cucchiar@mail.med.upenn.edu

Annals of Emergency Medicine

|July 29, 2008

Summary

This summary is machine-generated.

Identifying patients at high risk of stroke after a transient ischemic attack (TIA) is crucial. This review covers clinical risk stratification, imaging, and evidence-based acute and long-term prevention strategies for TIA.

More Related Videos

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

Related Experiment Videos

Last Updated: Jul 3, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia

Published on: August 18, 2015

Area of Science:

Neurology
Vascular Medicine
Stroke Prevention

Background:

Transient ischemic attack (TIA) evaluation presents challenges in identifying patients with high short-term stroke risk.
Clinical information and emerging brain/vascular imaging data aid in risk stratification.
Acute management of TIA, including hospitalization and antithrombotic therapy, lacks definitive evidence from controlled trials.

Purpose of the Study:

To review current strategies for short-term stroke risk stratification in transient ischemic attack (TIA) patients.
To discuss the role of clinical data and advanced imaging in TIA risk assessment.
To summarize evidence-based approaches for acute management and long-term prevention of stroke after TIA.

Main Methods:

Review of recently developed clinical risk stratification schemes for TIA.
Analysis of emerging data on brain and vascular imaging in TIA risk stratification.
Synthesis of evidence from large randomized trials on TIA management and stroke prevention.

Main Results:

Clinical information and imaging modalities are increasingly used to stratify TIA patient risk.
Evidence for acute management decisions (hospitalization, antithrombotics) in TIA is limited.
Robust evidence from randomized trials supports long-term stroke prevention strategies post-TIA.

Conclusions:

Accurate risk stratification is essential for managing patients with transient ischemic attack (TIA).
While acute TIA management remains controversial, strong evidence guides long-term stroke prevention.
Integrating clinical data and imaging can optimize TIA patient care and outcomes.